Trial Profile
Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary) ; Estradiol (Primary)
- Indications Genitourinary disorders; Postoperative complications
- Focus Therapeutic Use
- 30 Apr 2018 Status changed from recruiting to withdrawn prior to enrolment.
- 28 Sep 2016 New trial record